Molecular characterization of chromosomal band 5p15.33: A recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus

Leukemia Research

Volumn 37, Issue 3, 2013, Pages 280-286

  Schilling, Georgia ^a   Penas, Eva Maria Murga ^a,b   Janjetovic, Snjezana ^a   Oliveira Ferrer, Leticia ^a   Braig, Melanie ^a,c   Behrmann, Petra ^a   Bokemeyer, Carsten ^a   Dierlamm, Judith ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

5p15; CLPTM1L; Mantle cell lymphoma; Secondary chromosomal aberrations; TERT

Indexed keywords

ARTICLE; CHROMOSOME BAND; CLINICAL ARTICLE; CLPTM1L GENE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; MALE; MANTLE CELL LYMPHOMA; MOLECULAR DYNAMICS; ONCOGENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TERT GENE;

AGED; CELL LINE, TUMOR; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 5; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC LOCI; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MANTLE-CELL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TRANSLOCATION, GENETIC;

EID: 84872970639     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.10.009     Document Type: Article

References (28)

1. Jares P., Colomer D., Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007, 7(10):750-762.
2. Williams M.E., Swerdlow S.H., Rosenberg C.L., Arnold A. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res 1992, 52(19 Suppl.):5541s-5544s.
3. Lovec H., Grzeschizek A., Kowalski M.B., Möröy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J 1994, 13(15):3487-3495.
4. Hirt C., Schüler F., Dölken L., Schmidt C.A., Dölken G. Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood 2004, 104(3):904-905.
5. Rudolph C., Steinemann D., Von Neuhoff N., Gadzicki D., Ripperger T., Drexler H.G., et al. Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. Cancer Genet Cytogenet 2004, 153(2):144-150.
6. ISCN An international system for human cytogenetic nomenclature 2005, S. Karger, Basel. L.G. Shaffer, N. Tommerup (Eds.).
7. Dierlamm J., Baens M., Stefanova-Ouzounova M., Hinz K., Wlodarska I., Maes B., et al. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000, 96(September (6)):2215-2218.
8. Baerlocher G.M., Vulto I., de Jong G., Lansdorp P.M. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 2006, 1:2365-2376.
9. Rufer N., Brümmendorf T.H., Kolvraa S., Bischoff C., Christensen K., Wadsworth L., et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999, 190:157-167.
10. M'kacher R., Farace F., Bennaceur-Griscelli A., Violot D., Clausse B., Dossou J., et al. Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model. Cancer Genet Cytogenet 2003, 143(1):32-38.
11. Camps J., Salaverria I., Garcia M.J., Prat E., Beà S., Pole J.C., et al. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res 2006, 30(8):923-934.
12. Salaverria I., Espinet B., Carrió A., Costa D., Astier L., Slotta-Huspenina J., et al. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques. Genes Chromosomes Cancer 2008, 47(12):1086-1097.
13. Brassat U., Balabanov S., Bali D., Dierlamm J., Braig M., Hartmann U., et al. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells. Exp Hematol 2011, 39(1):66-76. e1-2. (Epub 2010 Oct 30).
14. Nagel I., Szczepanowski M., Martín-Subero J.I., Harder L., Akasaka T., Ammerpohl O., et al. Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies. Blood 2010, 116(8):1317-1319.
15. Rafnar T., Sulem P., Stacey S.N., Geller F., Gudmundsson J., Sigurdsson A., et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009, 41(2):221-227.
16. Chen X.F., Cai S., Chen Q.G., Ni Z.H., Tang J.H., Xu D.W., et al. Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genet Mol Res 2012, 11(February (1)):370-378.
17. Yamamoto K., Okamoto A., Isonishi S., Ochiai K., Ohtake Y. Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance. Cancer Lett 2001, 168(2):173-181.
18. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106(6):661-673.
19. Ladetto M., Compagno M., Ricca I., Pagano M., Rocci A., Astolfi M., et al. Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood 2004, 103(12):4644-4649.
20. Cottliar A.S., Panero J., Pedrazzini E., Noriega M.F., Narbaitz M., Rodríguez A., et al. Analysis of telomere length in mantle cell lymphoma. Eur J Haematol 2009, 83(5):433-438.
21. Yamamoto K., Okamoto A., Isonishi S., Ochiai K., Ohtake Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 2001, 280(February (4)):1148-1154.
22. James M.A., Wen W., Wang Y., Byers L.A., Heymach J.V., Coombes K.R., et al. Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. PLoS One 2012, 7(6):e36116. (Epub. 2012 Jun 4).
23. Abe M., Nozawa Y., Wakasa H., Ohno H., Fukuhara S. Characterization and comparison of two newly established Epstein-Barr virus-negative lymphoma B-cell lines, Surface markers, growth characteristics, cytogenetics, and transplantability. Cancer 1988, 61(3):483-490.
24. Jeon H.J., Kim C.W., Yoshino T., Akagi T. Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol 1998, 102(5):1323-1326.
25. Tucker C.A., Bebb G., Klasa R.J., Chhanabhai M., Lestou V., Horsman D.E., et al. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of mantle cell lymphoma. Leuk Res 2006, 30(4):449-457.
26. Daibata M., Kubonishi I., Miyoshi I. Differential tumorigenicity between Epstein-Barr virus genome-positive and genome-negative cell lines with t(11;14)(q13;q32) derived from mantle cell lymphoma. J Virol 1996, 70(12):9003-9007.
27. Raynaud S.D., Bekri S., Leroux D., Grosgeorge J., Klein B., Bastard C., et al. Expanded range of 11q13 breakpoints with differing patterns of Cyclin D1 expression in B-cell malignancies. Genes Chrom Cancer 1993, 8(2):80-87.
28. Estrov Z., Talpaz M., Ku S., Harris D., Van Q., Beran M., et al. Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia. Leuk Res 1998, 22(4):341-353.